Press Releases July 31, 2026 08:30 AM

Nasdaq Resumes Trading in Jiade Limited

Nasdaq Resumes Trading of Jiade Limited Class A Ordinary Shares after Temporary Halt

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
JDZG

Trading in Jiade Limited's Class A Ordinary Shares, which had been halted on June 4, 2026, resumed on July 31, 2026 at 12:00 p.m. Eastern Time on the Nasdaq stock exchange. The announcement comes directly from Nasdaq with no specific reasons or additional details provided about the resumption or prior trading halt.

Nasdaq Resumes Trading in Jiade Limited
JDZG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Trading in Jiade Limited's ordinary shares was halted on June 4, 2026 and has now resumed on July 31, 2026.
  • The company is listed on Nasdaq under the ticker symbol JDZG as Class A Ordinary Shares.
  • No specific details were provided regarding the reasons for the trading halt or any changes within the company.

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in Jiade Limited – Class A Ordinary Shares (Nasdaq: JDZG) at 12:00 p.m. Eastern Time on July 31, 2026. Trading in the company’s ordinary shares was halted on June 4, 2026 at 17:15:41 Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Contact:

Nasdaq MarketWatch
[email protected]

NDAQO


Risks

  • Uncertainty around the reason for the previous trading halt may cause some investor caution or volatility.
  • Lack of new information or updates may result in limited investor enthusiasm post-resumption.
  • Potential lingering regulatory or operational concerns that led to the halt might still affect the company in the near term.

More from Press Releases

Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026 Jasper Therapeutics Announces 1-for-30 Reverse Stock Split Nov 4, 2026